Fluxergy Announces $30 Million to Expand Manufacturing Capacity of Its One-hour Point-of-care Diagnostic Testing System in Response to COVID-19
PR84022
IRVINE, California, May 13, 2019, /PRNewswire-=KYODO JBN/--
Irvine, California-based Fluxergy LLC, a diagnostic test company, is making a
$30 million investment to expand its capability to scale production of the
Fluxergy Analyzer diagnostic testing system in response to the COVID-19
pandemic.
The Fluxergy system, utilizing state-of-the-art PCR and microfluidics
technology, has been shown to accurately identify the SARS-CoV-2 virus in one
hour in studies conducted by the company, and by physician-scientists at the
University of California San Diego. Fluxergy has started additional validation
studies at world-leading health systems and plans to continue making its
testing platform available as a Research Use Only (RUO) system for suitable
partners during the current public health emergency.
"We anticipate that our significant investment to step up our manufacturing
capability will enable Fluxergy to deliver as many as one million tests per
month by the end of 2020, reflecting our confidence in our technology as an
innovative solution to COVID-19 testing shortages," said Dr. Ali Tinazli, Chief
Commercial Officer of Fluxergy.
Fluxergy recently filed a request for an Emergency Use Authorization (EUA) with
the U.S. Food and Drug Administration (FDA) to permit medical sites with
CLIA-certified high complexity laboratories to begin using the company's
high-speed test system for COVID-19 in accordance with the scope of FDA's
authorization.
About Fluxergy
Fluxergy, launched in 2013 with funding support of principal investor and
Kingston Technology co-founder John Tu, seeks to provide a portable, easy to
use sample-to-answer POC platform that enables clinicians to cost-effectively
conduct a wide range of multiplex and multimodal in vitro diagnostic tests
(different types of tests all at once, up to 30 targets). Visit fluxergy.com
for more information.
Photo - https://mma.prnewswire.com/media/1167640/FluxergyAnalyzerSystem.jpg
Photo -
https://mma.prnewswire.com/media/1167641/Fluxergy_Co_Founder_President.jpg
CONTACT: Dr. Ali Tinazli, atinazli@fluxergy.com +1 (310) 467-1112
Source: Fluxergy
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。